G. B. Migliori (Tradate, Italy)
The risk of hepatotoxicity of anti-tuberculosis drugs in patients from regions with high prevalence of hepatitis B
T. Yildiz, A. Senyigit, S. R. Isik, C. Sinir, L. Akyildiz, H. Bayram (Diyarbakir, Turkey)
|  |
Outcome of multi-drug resistant tuberculosis in Belgrade
D. Mandic, D. Popovac (Belgrade, Yugoslavia)
| |
Evaluation of treatment outcomes for multidrug-resistant tuberculosis
V. Leimane, V. Skripconoka, E. Zarovska, I. Sture (Riga, Latvia)
| |
γδT lymphocytes in the peripheral blood of tuberculosis patients with and without HIV co-infection
A. C. C. Carvalho, A. Matteelli, S. Tedoldi, C. Casalini, P. Airò, L. Imberti, G. P. Cadeo, A. Beltrame, G. Carosi (Rio de Janeiro, Brazil; Brescia, Italy)
| |
Side effects observed in process of multidrug resistant tuberculosis management in tomsk oblast penitentiary system
A. D. Pasechnikov, K. V. Goncharova, A. A. Trusov, O. S. Kostornoy, S. P. Mishustin, Y. P. Karpeichik, S. D. Faraphonov (New York, United States Of America; Tomsk, Russia)
| |
The significance of positive smear results at T2 in pulmonary tuberculosis - Iasi (Romania) DOTS pilot study
Z. Tarevici, V. Mihai, T. Mihaescu (Iasi, Romania)
| |
Drag resistant M. tuberculosis among tuberculosis patients in prisons
G. S. Avdeev, P. S. Krivonos (Minsk, Belarus)
| |
Considerations upon the drug resistance spectrum of Mycobacterium tuberculosis
I. Strambu, I. P. Stoicescu, I. Andreescu, M. Trinca, D. Diaconescu, R. Tucra (Bucharest, Romania)
| |
Success in putting TB epidemic under control, implementing DOTS-strategy in the penitentiary system of Tomsk Oblast, Western Siberia, Russia
| |
Treatment outcome of multidrug resistant tuberculosis with second line drugs
A. Sorete Arbore, V. Cojocariu (Iasi, Romania)
| |
Economic inadequacy and TBC in Bulgaria and Yugoslavia
C. Korogiannos, A. Chalkias, F. Charizani, S. Boulia, G. Tatsis (Athens, Greece)
| |
Tuberculosis for HIV infected patients in Latvia
I. Priedulena, V. Leimane, E. Zarovska, G. Sture' (Riga, Latvia)
| |
Patterns of drug resistance in pulmonary tuberculosis: results of an open prospective study in Tanta, Egypt
A. A. Abu Hussein, H. M. Al-Akshar, A. R. Ads, S. El-Taieb (Tanta, Cairo, Egypt)
| |
Multidrug-resistant tuberculosis: treatment outcome after 18 months of invidualised therapy
G. Cicchitto, A. Vaghi, N. Grassi, S. Capato, G. Besozzi, S. De Lorenzo, G. B. Migliori, R. Centis (Garbagnate, Sondalo, Tradate, Italy)
| |
Therapeutical problems related to drug-resistance in terms of DOTS
A. A. Torossian, A. Garova, G. Belev, V. Hodgev, S. Kartev, P. Mandulova (Plovdiv, Bulgaria)
| |
Comparison of Mycobacterium tuberculosis drug susceptibility tests by nucleic acid amplification and classic technique
A. M. Skrahina, O. M. Zalutskaya, E. N. Nikolenko, A. E. Skrahin, A. Roth (Minsk, Belarus; Berlin, Germany)
| |
Susceptibility of Mycobacterium tuberculosis strains to fluoquinolones, obtained from chronic patients with multidrug resistant pulmonary tuberculosis
S. A. Cherenko, V. M. Petrenko, A. A. Jurilo, M. T. Klimenko (Kyiv, Ukraine)
| |
Tolerance of cycloserine in combined therapy of tuberculosis
G. B. Sokolova, P. V. Senchihin, Y. V. Lazareva (Moscow, Russia)
| |
What do the Macedonian citizens know about tuberculosis?
M. Trajcevska, A. Sandevski, N. Minovska, L. Seckova (Skopje, Macedonia)
| |